Rotigotine is safe and efficacious in Atypical Parkinsonism Syndromes induced by both a-synucleinopathy and tauopathy
Davide Vito Moretti, Giuliano Binetti, Orazio Zanetti, Giovanni Battista Frisoni IRCCS San Giovanni di Dio Fatebenefratelli, Brescia, ItalyAbstract: Transdermal rotigotine (RTG) is a non-ergot dopamine agonist (D3>D2>D1), and is indicated for use in early and advanced Parkinson&r...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-06-01
|
| Series: | Neuropsychiatric Disease and Treatment |
| Online Access: | http://www.dovepress.com/rotigotine-is-safe-and-efficacious-in-atypical-parkinsonism-syndromes--a17123 |